ILMN vs LH — Key Metrics

Metric ILMN (ILLUMINA INC) LH (LABCORP HOLDINGS INC)
Price210.01370.78
Market Cap31.75 Billion30.11 Billion
P/E (TTM)35.7230.22
P/B (Quarterly)11.3463.317
P/S (TTM)7.02.06
Net Profit Margin (TTM)19.76.9
Gross Margin (TTM)67.929.0
ROE (TTM)31.511.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

ILLUMINA INC
vs
 
LABCORP HOLDINGS INC
 
ILLUMINA INC
vs
 
LABCORP HOLDINGS INC
Performance Comparison
AI Model Recommendation
ILMN · ILLUMINA INC

Outperform

36
UnderperformOutperform
LH · LABCORP HOLDINGS INC

Underperform

-32
UnderperformOutperform
Recommendation Summary

Stock ILMN is projected to outperform the market, stock LH is projected to underperform the market. Upfront Recommendation: ILMN.

Financial Metrics
Prices delayed ~15 min
ILMN Metrics LH
$210.01 Price $370.78
— Market Capitalization —
35.72 Price to Earnings Ratio 30.22
7.0 Price to Sales 2.06
30.04 Price to FCF Ratio 23.4
10.31 Price to Gross Profit 7.12
10.46 Price to Current Assets 7.59

ILMN vs LH at a glance

Illumina INC (ILMN) and Labcorp Holdings INC (LH) are both Diagnostics & Research companies in the Healthcare sector. They are similar in size: $31.8 billion and $30.1 billion in market value.

On trailing-twelve-month figures, ILMN trades at 35.7 times trailing earnings and LH at 30.2; net profit margins are 19.7% and 6.9%.

The Upfront Investment model currently rates ILMN Outperform and LH Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.